Filter Options | |||||
---|---|---|---|---|---|
Public title | Scientific title | Subject ID | |||
Registration Status | Registration number | Secondary ID | |||
Applicant | Study leader | Year | |||
Primary sponsor | Secondary sponsor | Source(s) of funding | |||
Target disease | Target disease code | Study type | |||
Study phase | Study design | Study execute time |
From To |
||
Recruiting status | Gender | Sign the informed consent | |||
Countries of recruitment and research settings |
Nation(Area):Province:City: Institution:Level of the institution: |
||||
Intervention | Intervention code | Approved by ethic committee | |||
Calculated Results after the Study Completed public access |
Statistical results after completion of the test file upload |
||||
More Options |
86 trials have been registered
Historical versions | Registration number | Public title | Type | Registration time |
---|---|---|---|---|
Historical Versions | ChiCTR2200060517 |
Silodosin as a Medical Expulsive Therapy for Distal Ureteral Stones in the Pakistani Population Dr. Kashif Bangash |
Interventional | 2022/06/04 |
Historical Versions | ChiCTR2200057135 |
Alagumoorthi Gandhisubramanian |
Interventional | 2022/03/01 |
Historical Versions | ChiCTR2100054617 |
QIU XICHENHUI |
2021/12/21 | |
Historical Versions | ChiCTR2100054112 |
Quality Education Fund |
Interventional | 2021/12/09 |
Historical Versions | ChiCTR2100052225 |
Chinese University of Hong Kong |
Interventional | 2021/10/23 |
Historical Versions | ChiCTR2100052120 |
NIL |
Interventional | 2021/10/19 |
Historical Versions | ChiCTR2100044870 |
Nil |
Interventional | 2021/03/30 |
Historical Versions | ChiCTR2100044025 |
nil |
Interventional | 2021/03/06 |
Historical Versions | ChiCTR2100042595 |
University of Health Sciences, Lahore, Pakistan |
Interventional | 2021/01/23 |
Historical Versions | ChiCTR2000040265 |
Impact of COVID-19 pandemic on Hepatobiliary and Pancreatic surgical services Nil |
Observational | 2020/11/26 |